Detalles de la búsqueda
1.
A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors.
Oncologist
; 29(1): e47-e58, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37619245
2.
BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes With Targeted Therapies in Real-World Cases of Colorectal Cancer.
Oncologist
; 28(3): e171-e174, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779536
3.
Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay.
Oncologist
; 28(4): 319-326, 2023 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36866462
4.
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer.
Int J Gynecol Cancer
; 33(4): 504-513, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36750267
5.
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer.
Prostate
; 82(7): 867-875, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35286728
6.
Real-World Comprehensive Genomic Profiling Success Rates in Tissue and Liquid Prostate Carcinoma Specimens.
Oncologist
; 27(12): e970-e972, 2022 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36069892
7.
Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation.
Oncologist
; 27(8): 655-662, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35552752
8.
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.
Cancer
; 127(24): 4557-4564, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34379803
9.
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
Oncologist
; 26(10): 835-844, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34105210
10.
Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer.
J Urol
; 202(4): 732-741, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31216253
11.
Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.
BJU Int
; 120(5B): E30-E44, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27539393
12.
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
BMC Cancer
; 16(1): 744, 2016 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27658492
13.
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol
; 8: e2300562, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547419
14.
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation.
Clin Cancer Res
; 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526394
15.
The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate Cancer.
Clin Genitourin Cancer
; 22(1): e163-e169.e1, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37978032
16.
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types.
Clin Cancer Res
; 30(4): 836-848, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38060240
17.
Not all TMB assays are the same: Clinical validity of robust algorithmic germline filtering.
Cancer Cell
; 41(5): 819-820, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37059103
18.
Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations.
Prostate Cancer Prostatic Dis
; 26(1): 188-193, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36402814
19.
Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer.
Eur Urol Open Sci
; 55: 45-49, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37662703
20.
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis.
J Immunother Cancer
; 11(1)2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36650021